Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Accounts Payables (2020 - 2025)

Historic Accounts Payables for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $3.6 million.

  • Rapid Micro Biosystems' Accounts Payables rose 5422.93% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 5422.93%. This contributed to the annual value of $2.5 million for FY2024, which is 2848.45% up from last year.
  • Latest data reveals that Rapid Micro Biosystems reported Accounts Payables of $3.6 million as of Q3 2025, which was up 5422.93% from $3.3 million recorded in Q2 2025.
  • In the past 5 years, Rapid Micro Biosystems' Accounts Payables registered a high of $5.4 million during Q4 2022, and its lowest value of $1.2 million during Q1 2024.
  • Moreover, its 5-year median value for Accounts Payables was $2.6 million (2021), whereas its average is $2.8 million.
  • As far as peak fluctuations go, Rapid Micro Biosystems' Accounts Payables tumbled by 6374.65% in 2023, and later skyrocketed by 12637.46% in 2025.
  • Rapid Micro Biosystems' Accounts Payables (Quarter) stood at $3.9 million in 2021, then soared by 37.63% to $5.4 million in 2022, then crashed by 63.65% to $2.0 million in 2023, then rose by 28.48% to $2.5 million in 2024, then skyrocketed by 41.7% to $3.6 million in 2025.
  • Its Accounts Payables stands at $3.6 million for Q3 2025, versus $3.3 million for Q2 2025 and $2.6 million for Q1 2025.